CENTRAL TRUST Co Boosts Position in Envision Healthcare Co. (NYSE:EVHC)

CENTRAL TRUST Co increased its position in shares of Envision Healthcare Co. (NYSE:EVHC) by 10.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,989 shares of the company’s stock after buying an additional 556 shares during the period. CENTRAL TRUST Co’s holdings in Envision Healthcare were worth $376,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in shares of Envision Healthcare during the first quarter valued at about $135,000. Korea Investment CORP acquired a new stake in shares of Envision Healthcare during the first quarter valued at about $141,000. Ameritas Investment Partners Inc. acquired a new stake in shares of Envision Healthcare during the first quarter valued at about $172,000. First Interstate Bank acquired a new stake in shares of Envision Healthcare during the first quarter valued at about $184,000. Finally, Daiwa Securities Group Inc. increased its stake in shares of Envision Healthcare by 60.9% in the first quarter. Daiwa Securities Group Inc. now owns 3,169 shares of the company’s stock valued at $194,000 after buying an additional 1,200 shares in the last quarter. Institutional investors and hedge funds own 64.75% of the company’s stock.

Envision Healthcare Co. (NYSE:EVHC) traded up 0.23% during mid-day trading on Friday, reaching $52.89. The company’s stock had a trading volume of 1,356,946 shares. The company has a 50 day moving average of $59.52 and a 200-day moving average of $61.20. The stock’s market cap is $6.19 billion. Envision Healthcare Co. has a 52-week low of $51.44 and a 52-week high of $74.75.

Envision Healthcare (NYSE:EVHC) last released its quarterly earnings data on Monday, August 7th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.04. The firm had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare had a positive return on equity of 5.35% and a negative net margin of 7.35%. The business’s revenue for the quarter was up 156.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.34 earnings per share. Equities analysts forecast that Envision Healthcare Co. will post $1.40 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This article was reported by Community Financial News and is the property of of Community Financial News. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.com-unik.info/2017/08/11/central-trust-co-boosts-position-in-envision-healthcare-corporation-nyseevhc-updated-updated-updated.html.

A number of research firms have recently weighed in on EVHC. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Envision Healthcare in a research note on Monday, July 24th. Royal Bank Of Canada raised their price target on Envision Healthcare from $72.00 to $77.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 27th. Zacks Investment Research raised Envision Healthcare from a “strong sell” rating to a “buy” rating and set a $70.00 price target for the company in a research note on Tuesday, July 4th. Canaccord Genuity reaffirmed a “buy” rating and set a $86.00 price target on shares of Envision Healthcare in a research note on Tuesday, April 18th. Finally, BidaskClub raised Envision Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, June 17th. One analyst has rated the stock with a sell rating, two have issued a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $71.56.

In other Envision Healthcare news, insider Robert Jon Coward sold 1,500 shares of the company’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $62.69, for a total value of $94,035.00. Following the sale, the insider now owns 97,863 shares in the company, valued at $6,135,031.47. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 3.10% of the stock is owned by corporate insiders.

About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

What are top analysts saying about Envision Healthcare Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare Co. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit